Candel Therapeutics annual operating margin
2020
2021
2022
Candel Therapeutics Operating Margin Growth & History (CADL)
Candel Therapeutics's operating margin was −27,777.60% for fiscal 2022.
View full Candel Therapeutics company overviewCandel Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −27,777.60% | −7196.80 pp |
| 2021 | 2021-12-31 | −20,580.80% | −9532.80 pp |
| 2020 | 2020-12-31 | −11,048.00% | — |
Candel Therapeutics quarterly operating margin
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −25,318.75% | −1134.38 pp |
| Q3 2022 | 2022-09-30 | −28,648.39% | −2748.39 pp |
| Q2 2022 | 2022-06-30 | −28,235.48% | −11135.48 pp |
| Q1 2022 | 2022-03-31 | −28,987.10% | −13964.52 pp |
| Q4 2021 | 2021-12-31 | −24,184.38% | −15316.63 pp |
| Q3 2021 | 2021-09-30 | −25,900.00% | −17451.61 pp |
| Q2 2021 | 2021-06-30 | −17,100.00% | — |
| Q1 2021 | 2021-03-31 | −15,022.58% | — |
| Q3 2020 | 2020-09-30 | −8,867.74% | — |
| Q2 2020 | 2020-06-30 | −8,448.39% | — |
Candel Therapeutics operating margin trends
Across the available reported history, Candel Therapeutics's operating margin decreased from −20,580.80% to −27,777.60%, a change of −7196.80 percentage points. The latest reported quarter, Q4 2022, shows −25,318.75%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Candel Therapeutics filings at SEC.gov ↗